Roflumilast 500 mcg Tablets
Roflumilast 500 mcg Tablets are a prescription respiratory medicine used for the maintenance treatment of severe Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis and a history of frequent exacerbations. The medicine helps reduce inflammation in the lungs and supports better respiratory function in patients with chronic airway diseases.
Composition
Each film-coated tablet contains:
Roflumilast 500 mcg
Therapeutic Category
Respiratory Medicine
Phosphodiesterase-4 (PDE4) Inhibitor
Anti-inflammatory Agent for COPD Management
Treatment Applications
Roflumilast 500 mcg Tablets are commonly prescribed for:
Severe Chronic Obstructive Pulmonary Disease (COPD)
Chronic Bronchitis associated with COPD
Prevention of COPD flare-ups and exacerbations
Long-term respiratory disease management
Patients requiring additional anti-inflammatory respiratory support
Mechanism of Action
Roflumilast works by selectively inhibiting phosphodiesterase-4 (PDE4), which helps decrease inflammation in the lungs. This action contributes to reducing airway swelling, improving breathing capacity, and lowering the frequency of COPD exacerbations.
Dosage and Administration
Use strictly as directed by a qualified healthcare professional.
Typically administered as one tablet once daily.
May be taken with or without food.
Tablets should be swallowed whole with water.
Do not exceed the prescribed dosage.
Storage Instructions
Store below 30°C.
Protect from moisture and direct sunlight.
Keep tablets in original packaging.
Keep out of reach of children.
Benefits of Roflumilast 500 mcg
Reduces COPD exacerbations
Supports long-term lung function management
Helps decrease airway inflammation
Convenient once-daily dosing
Suitable for maintenance treatment plans
South Africa Respiratory Market Focus
South Africa continues to experience significant demand for respiratory care products due to smoking-related diseases, environmental pollution, occupational lung disorders, and chronic respiratory illnesses.
High-Demand Provinces for Respiratory Products in South Africa
Gauteng
Western Cape
KwaZulu-Natal
Eastern Cape
Free State
Mpumalanga
Limpopo
North West
Northern Cape
Healthcare facilities, respiratory specialists, pharmacies, hospitals, and medical distributors across these provinces regularly seek quality respiratory medications for COPD and chronic bronchitis management.
Supply & Distribution Opportunities
Roflumilast 500 mcg Tablets are suitable for:
Hospitals
Pulmonology Clinics
Respiratory Care Centers
Government Healthcare Procurement
Private Pharmacies
Medical Distributors
Pharmaceutical Importers
Why Choose Cordium Pharmaceuticals?
Quality-focused pharmaceutical manufacturing
Export-ready documentation support
Reliable international supply chain
Bulk order fulfillment capability
Dedicated customer support
Contact Information
Cordium Pharmaceuticals Pvt. Ltd.
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com
For distributor inquiries, pharmacy supply requirements, hospital procurement, and international sourcing of respiratory medicines, contact our export team today.